Atlas Trials

Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection

Clinical trial NCT06626555 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06626555
Sponsor
University College, London
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
HIV
Start date
2024-10-01
Primary completion
2026-03-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.